Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesPayablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Quantumzyme (QTZM) Retained Earnings (2016 - 2026)

Quantumzyme (QTZM) has 5 years of Retained Earnings data on record, last reported at -$5.7 million in Q4 2025.

  • For Q4 2025, Retained Earnings changed N/A year-over-year to -$5.7 million; the TTM value through Oct 2025 reached -$5.7 million, changed N/A, while the annual FY2025 figure was -$5.6 million, 3.66% down from the prior year.
  • Retained Earnings reached -$5.7 million in Q4 2025 per QTZM's latest filing, down from -$5.6 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$5.4 million in Q3 2024 and bottomed at -$5.7 million in Q4 2025.